NikkoAM ETFs product update

As the US Federal Reserve accelerates the reduction of its monthly bond purchases and signals three interest rate hikes in 2022, here's what Nikko AM has to say about its impact on Singapore's growth this year as it provides updates on a few of its ETFs.

Nikko Asset Management
Nikko Asset Management07 Feb 2022 2213 Views
NikkoAM ETFs product update

Fund specific news/market analysis

1. Nikko AM Singapore STI ETF

The Straits Times Index rose 2.91% in December
Singapore stocks turned in gains for December, despite news that the US Federal Reserve would accelerate the reduction of its monthly bond purchases and signalling three interest rate hikes in 2022. Anxiety about the Omicron COVID-19 variant also eased, with the Singapore government loosening COVID-19 workplace restrictions, which will allow 50% of fully-vaccinated employees to return to the office from 1 January. The city-state is also pressing forward with its vaccination programme, having extended vaccination to children aged five to 11, as well as expanding its vaccine booster programme to include those aged 18 to 29.

For the month, the Straits Times Index (STI) grew 2.91% on a total return (TR) basis in Singapore dollar (SGD) terms. In terms of sectors, financials and utilities were the best performers, returning 6.53% and 6.38% respectively on a month-on-month (MoM) TR basis. At the other end of the spectrum, information technology and industrials were the worst performers, returning -1.08% and -1.00% respectively (on a TR basis) for the month.

Of the 30 component stocks in the index, DBS Group Holdings, Sembcorp Industries and United Overseas Bank were the three best performers in December with MoM TR gains of 9.34%, 6.38% and 5.61% respectively. Conversely, Dairy Farm International Holdings, Hongkong Land Holdings and Jardine Matheson Holdings were December’s worst performing STI stocks, with MoM TR losses of 9.87%, 5.32% and 4.42% respectively.

Sembcorp Industries’ UK unit to build Europe’s largest battery energy storage system
Singapore-based energy and utilities group Sembcorp Industries announced on 14 December that its wholly owned subsidiary in the United Kingdom (UK)—Sembcorp Energy UK—plans to construct Europe's largest energy storage system at its Wilton International industrial site. The development of this 360-megawatt (MW) battery energy storage system will also make a significant contribution to the UK’s Net Zero targets by ensuring the resilience of the electricity network and further facilitate the accelerating growth of renewables. In separate news, another unit of Sembcorp Industries, Sembcorp Utilities, has teamed up with Vietnam’s BCG Energy to develop up to 1.5 gigawatts of wind and solar renewable energy projects in Vietnam. The first phase of the collaboration will involve an initial investment of US dollar (USD) 30 million to develop a 550 MW portfolio of nearshore and onshore wind assets across three provinces. Sembcorp Industries was one of the best performing STI-component stocks in December.

Jardine Matheson upsized its share repurchase programme
In an announcement made on 8 December, Hong Kong-based multinational conglomerate Jardine Matheson Holdings (JMH) revealed plans to double the amount of its share buyback scheme to USD 500 million. Previously, JMH launched a share buyback programme in end-September to repurchase up to USD 250 million of shares by 30 June 2022. JMH mentioned that it was very close to achieving this target and reiterated that the purpose of the share buyback plan was to reduce the capital of the company, in line with Jardine Matheson Group's previously announced capital allocation policy. Jardine Matheson Holdings was one of the worst performing STI-component stocks in December.


2.  Nikko AM-StraitsTrading Asia ex Japan REIT ETF 

Asian REITs had a mixed month

Asian stocks tracked gains in Wall Street during December, despite the US Federal Reserve saying that it would end its bond-buying programme in March and signalling three interest rate hikes in 2022 to tackle persistent inflation. However, easing worries about the impact of the COVID-19 Omicron-variant did support market sentiment. Overall, regional REITs had a mixed month, with the FTSE EPRA Nareit Asia ex Japan REITs 10% Capped Index returning 0.81% in SGD terms for the month. The FTSE ST Real Estate Investment Trusts Index gained 1.63% in SGD terms, while the Hang Seng REIT Index Total Return fell 0.67% in Hong Kong dollar (HKD) terms. In comparison, general equities in Asia returned 1.27% in US dollar (USD) terms in December, according to the MSCI AC Asia-ex-Japan index. The US 10-year treasury yields expanded while the Singapore 10-year government bond yield compressed over the month.

At the sector level, specialised and healthcare REITs were the best performers in December, while retail and office REITs were the worst performers. At the individual REIT level, Mapletree North Asia Commercial Trust, First REIT and Keppel DC REIT were the best performers in December. Conversely, Embassy Office Parks REIT, Sunlight REIT and Manulife US REIT were the worst performers for the month.


Mapletree North Asia Commercial Trust to merge with Mapletree Commercial Trust

Mapletree North Asia Commercial Trust (MNACT), a Singapore-listed North Asia-focused REIT, is set to be absorbed by Mapletree Commercial Trust (MCT) via a proposed merger announced on 31 December. The combined entity, to be named Mapletree Pan Asia Commercial Trust, will constitute 18 commercial assets across Singapore, China, Hong Kong, Japan and South Korea, with assets under management of approximately SGD 17.1 billion. Mapletree’s new flagship commercial REIT is also expected to have a market capitalisation of around SGD 10.5 billion, making it one of Asia’s largest REITs. To be completed via a trust scheme, the merger will see shareholders in MNACT receive a scheme consideration of SGD 1.1949 for each unit held. MNACT owners can opt to receive either 0.5963 new MCT units at an issue price of SGD 2.0039 apiece, or a combination of 0.5009 consideration units and SGD 0.1912 in cash. Mapletree North Asia Commercial Trust was one of the best performing Asian REITs in December.


Manulife US REIT completed acquisition of three US office properties

Manulife US REIT—Asia’s first pure-play US office REIT—has officially completed its proposed acquisition of three office park assets in Phoenix and Portland in the United States, which was first announced at end-November. The three properties (Tanasbourne Commerce Centre, Park Place and Diablo Technology Park) were purchased for a combined USD 201.6 million and will boost the REIT’s exposure to high-growth markets and tenants, especially in the technology and healthcare sectors. Manulife US REIT’s portfolio occupancy has now increased to 91.3% while the weighted average lease expiry across the enlarged portfolio went up to 5.2 years. Manulife US REIT will fund its proposed acquisition through a combination of loans and proceeds from a private placement, which closed at USD 0.649 per unit. Manulife US REIT was one of the worst performing Asian REITs in December.


3. ABF Singapore Bond Index Fund

Singapore Government Securities (SGS) outperformed US Treasuries (USTs) in December
US Treasuries (USTs) saw yields ended marginally higher at 1.51% in December. US non-farm payroll printed at 210,000 for the month of November, below market consensus of roughly 570,000. Despite the downside surprise, the unemployment rate fell to 4.2% from 4.6%. On the other hand, the CPI surprised on the upside at 6.8% while US core CPI printed 4.9%. During the December Federal Open Market Committee (FOMC) meeting, the FOMC announced that it will ramp up the speed at which it pares its bond purchases which will lead to the end of their quantitative easing programme a few months earlier than expected. The updated FOMC projection showed that most officials expect to raise rates about three times in 2022. Meanwhile, concerns about a new COVID-19 variant (Omicron) rose, as Omicron-related cases spread rapidly in various countries.

SGS outperformed USTs in December, with 10-year SGS yields down 5 bps to 1.64%. Long-dated SGS yields rose towards month-end, with the 30-year SGS yield ending December 17 bps higher at 2.09%, ahead of a busy SGS issuance schedule in 1Q2022, concentrating on mid-dated SGS securities. The outperformance of SGS has been supported by: (1) a reduction in SGS Market Development (MD) bond duration supply in 2022, especially in the first half, when no long end (>10 years) SGS MD auction is scheduled; (2) the Monetary Authority of Singapore’s (MAS) plan to issue a new long end SGS (Infrastructure) bond around mid-2022 based on market conditions via debt syndication, which is likely to match demand from structural investors; and (3) as the MAS allowed the SGD to appreciate by slightly raising the SGD nominal effective exchange rate (NEER) slope in October 2021, with expectations of further foreign exchange policy tightening in 2022. Government bonds underperformed sub-sovereign securities, with the Markit iBoxx ABF Singapore Govt Total Return (TR) Index returning at -0.22%, compared to -0.01% monthly returns for the Markit iBoxx ABF Singapore Sub-Sovereigns TR Index.


Property curbs introduced to help cool the housing market

Singapore introduced residential property curbs for the first time since 2018 to cool a surge in home prices over the past year. This did not come as a surprise, as the MAS had highlighted elevated leverage risks as rates rise in its 2021 Financial Stability Review. Tighter measures include higher additional stamp duties (Additional Buyer's Stamp Duty) for second and subsequent properties, as well as lowering of the total debt servicing ratio (TDSR) from 60% to 55%. The government also intends to release additional land supply, which should alleviate the tight market with less than one year worth of supply for the mass market segment.

All materials and contents found in this site are strictly for general circulation and informational purposes only and should not be considered as an offer, or solicitation, to deal in any of the funds or products found/identified in this site. While iFAST Financial Pte Ltd ("IFPL") has tried to provide accurate and timely information, there may be inadvertent delays, omissions, technical or factual inaccuracies and typographical errors. Any opinion or estimate contained in this report is made on a general basis and neither IFPL nor any of its servants or agents have given any consideration to nor have they or any of them made any investigation of the investment objective, financial situation or particular need of any user or reader, any specific person or group of persons. You should consider carefully if the products you are going to purchase are suitable for your investment objective, investment experience, risk tolerance and other personal circumstances. If you are uncertain about the suitability of the investment product, please seek advice from a financial adviser, before making a decision to purchase the investment product. Past performance is not indicative of future performance. The value of the investment products and the income from them may fall as well as rise. Opinions expressed herein are subject to change without notice. In respect of any matters arising from, or in connection with the said research analyses or research reports, recipients of the report are to contact IFPL at 10 Collyer Quay, #26-01 Ocean Financial Centre Building, Singapore 049315, or by telephone at +65 6557 2853. Where the report contains research analyses or research reports from a foreign research house and if the recipient of such research analyses or research reports is not an accredited investor, expert investor, institutional investor or an ex-accredited investor, IFPL accepts legal responsibility for the contents of such analyses or reports to such persons only to the extent as required by law. Please note that only certain security(ies) herein are available to all investors, while the rest are only available for certain persons to invest in, such as Accredited Investors (as defined in the Securities and Futures Act) or one who invests at least S$200,000 (or its equivalent currency) per transaction. To qualify as an Accredited Investor, one needs to submit a declaration form and certain relevant supporting documents, according to iFAST’s prevailing policies and procedures.

Please read our full disclaimers on the website at ( https://secure.fundsupermart.com/fsmone/policies/328125/investment-account-terms-&-conditions).

iFAST Financial Pte Ltd (IFPL) (registered address: 10 Collyer Quay #26-01 Ocean Financial Centre Singapore 049315, Telephone: 6557 2000) holds the Financial Advisers Licence issued by the Monetary Authority of Singapore ('MAS') to conduct regulated activities of advising on securities, marketing of collective investment schemes and arranging of any contract of insurance in respect of life policies, other than a contract of reinsurance and the Capital Markets Services Licence issued by the MAS to conduct regulated activities of dealing in securities and providing custodial services for securities. While IFPL has made every effort to ensure the independence of the report's contents, IFPL's nature of business is such that IFPL and its connected and associated entities together with their respective directors, officers and staff may be involved in providing dealing or investment-related services in the abovementioned securities, and have taken or may take positions in the securities mentioned in this report, and may also act as the principal for any buy or sell trades.